Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 5.02, 9.01 · 8-K

Solventum Corporation

SOLVNYSEEQUITYCurrent

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On May 21, 2026, the Talent Committee (the “Committee”) of the Board of Directors of Solventum Corporation (the “Company”) adopted and approved the Solventum Executive Severance Plan and Summary Plan Description (the “Severance Plan”), effective June 1, 2026.…

Filed May 27, 2026Accepted May 27, 2026, 4:23 PM EDTCIK 1964738Accession 0001964738-26-000031
Share

Company context

Current securities

Recent company filings

  1. 3 filingAug 18, 2026
  2. 10-Q filingAug 5, 2026
  3. Results of Operations and Financial ConditionAug 5, 2026
  4. Regulation FD Disclosure · Other EventsAug 5, 2026
  5. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsJul 20, 2026

Registered securities in this filing

SOLVENTUM CORPORATION · 8-K · Filed 2026-05-27

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, Par Value $.01 Per Share

Symbol
SOLV
Exchange
NYSE
Classification
COMMON
Status
Current
Filing context

Context: c-1

Dimensions: Not supplied

Accession 000196473826000031 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 5.02, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On May 21, 2026, the Talent Committee (the “Committee”) of the Board of Directors of Solventum Corporation (the “Company”) adopted and approved the Solventum Executive Severance Plan and Summary Plan Description (the “Severance Plan”), effective June 1, 2026. The Severance Plan provides severance payments and benefits to certain eligible employees of the Company, including executive officers, in the event of an involuntary termination of employment other than for misconduct or a voluntary termination for good reason, subject to eligibility conditions and the execution of a severance agreement, which includes a release of claims. Under the Severance Plan, eligible participants generally may receive cash severance based on a period of continued base salary (ranging from 9 months to up to 24 months), continued eligibility for incentive compensation, a lump‑sum payment for continued medical and dental coverage, and specified treatment of equity awards, in each case subject to the terms of the Severance Plan. The Severance Plan replaces and supersedes the Company’s prior Executive Severance Plan and Summary Plan Description, effective April 1, 2024 (the “Prior Plan”). The Severance Plan includes several changes compared to the Prior Plan, including, but not limited to: • The Severance Plan provides for 12 months of base salary plus prorated incentive compensation following an eligible termination for direct reports of the Chief Executive Officer, provided that currently serving executive officers who are eligible to receive 18 months of base salary remain eligible for such amount for a period of two years. • The Severance Plan provides for a lump-sum cash payment equal to the amount of the COBRA premiums required for continued medical and dental coverage for the severance period for the Chief Executive Officer and direct reports of the Chief Executive Officer and their dependents. • The Severance Plan provides for forfeiture of certain post‑effective date awards and limited vesting for pre‑effective date awards, in each case subject to applicable plan and award terms. Consistent with the terms of the Severance Plan, certain outstanding compensation and equity arrangements and other rights that arose under the Prior Plan or were granted prior to the effective date of the Severance Plan will continue to be governed by their existing terms (including, for example, treatment of certain equity awards granted prior to the effective date), and the Severance Plan includes provisions intended to preserve such grandfathered rights. The Severance Plan also includes customary provisions relating to plan administration, compliance with Sections 280G and 409A of the Internal Revenue Code, and the Company’s right to amend or terminate the plan, subject to certain limitations. The foregoing description of the Severance Plan is qualified in its entirety by reference to the Severance Plan, which is attached hereto as Exhibit 10.1 and incorporated herein by reference.

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.